Article – The New Big Data Application That Is Reshaping Clinical Trials
The new big data application is reshaping clinical trials. Someone on the…
Read more
Article – Matching Patients To Trials: Cerba Research’s Digital Tool For Improved Patient Recruitment
Patient recruitment has always been a challenge for clinical research, with most…
Read more
Case Study – Phase 3 CAR-T vs SOC In Relapse Refractory Multiple Myeloma (RRMM)
Discover how effective we are in immunophenotyping for a Car-T therapy take…
Read more
Case Study – Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we manage routine and specialty test for a Phase 1…
Read more
Case Study – Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we managed cell isolation and counts among other routine and…
Read more
Article – The Value Of Biomarkers From Discovery To Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Article – Cerba Research Expands U.S. Immuno-Oncology Center Of Excellence To Strengthen Its Precision Medicine Offerings
Cerba Research established its United States presence as a leading clinical diagnostics…
Read more
Case Study – How Cerba Research Helped Advance A Phase 1B Study In The Middle Of A Pandemic And Brexit
A two-country clinical trial that involves a nasopharyngeal swab and two assays…
Read more
Case Study – Tech Transfer IFE Reflex Assay China
A Biotech Company in China required our scientific expertise for the Tech…
Read more
Case Study – Pediatric Phase I/II/III Study In X-Linked Myotubular Myopathy (XLMTM)
Lab support for a global pediatric trial for the rare neuromuscular disease,…
Read more
Case Study – Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)
Lab support for a global pediatric trial for the rare genetic neurodegenerative…
Read more
Case Study – Lab Support For The Largest Global Phase III NASH Study To Date
In a meta-analysis of several studies using various methodologies, worldwide prevalence of…
Read more
Case Study – Ten-Day Study Start & Customer Test Kit Build at the Height of a Pandemic
On the upswing of the COVID-19 pandemic, an ID focused pharmaceutical client…
Read more
Case Study – Retrospective Biomarker Analysis Performed To Measure Tumor-infiltrating CD39+ CD8+ T Cells in Metastatic Renal Cell Carcinoma
A biotech conducted a phase II study to analyze the percent expression…
Read more
Case Study – Phase 3 Clinical Trial On The Efficacy And Safety Of A New Therapy In The Treatment Of Uncomplicated Influenza
Cerba Research performed a randomized, double-blind, placebo-controlled trial to evaluate the efficacy…
Read more
Case Study – Phase 2c Clinical Trial On The Efficacy, Safety, And Tolerability Of Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS TB) Treatment
Cerba Research performed an open-label, partially randomized trial to evaluate the efficacy,…
Read more
Case Study – DIRA Assay Testing For Daratumumab Clinical Trials
Discover in this case study how a daratumumab-Specific Immunofixation Electrophoresis Reflex Assay…
Read more
Case Study – Multiple Myeloma efficacy and safety of 2 different combination therapies
Discover how our team of experts performed a multicenter, randomized, open-label study…
Read more
Case Study – Multiple Myeloma
Discover how our experts performed a randomised, open-label, multicentre phase 3 study…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.
Contact Us